Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

Wintertime Brings Increased IHCA Risk, US Data Show

Caitlin E. Cox

June 26, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Daily News

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Michael O'Riordan

February 10, 2021

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Daily News

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

Todd Neale

August 13, 2018

Advertisement

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Wintertime Brings Increased IHCA Risk, US Data Show

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Observational Study Supports Continuing Oral Anticoagulation During PCI

Safe to Upgrade From Pacemaker or Defibrillator to CRT

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content